Cited by 251Smoking Behavior and CessationCannabis and Cannabinoid ResearchNicotinic Acetylcholine Receptors Study

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

Cohen, Caroline, Perrault, Ghislaine, Griebel, Guy, Soubrié, Philippe·2005·Neuropsychopharmacology

Open this paper in CoChat — free account

Abstract

Conditioned stimuli are important for nicotine dependence and may trigger craving and relapse after prolonged nicotine abstinence. However, little is known about the pharmacology of this process. Among the systems that have been shown to play a role in drug-seeking behavior is the endocannabinoid transmission. Therefore, the present study examined the resistance to extinction of drug-seeking behavior elicited by nicotine-associated environmental stimuli and the effects of the selective CB1 cannabinoid antagonist rimonabant (SR141716) on the reinforcing effects of nicotine-related stimuli. Rats were trained to self-administer nicotine (0.03 mg/kg/injection, i.v.) under conditions in which responding was reinforced jointly by response-contingent nicotine injections and stimuli (light and tone). After self-administration acquisition, nicotine was withdrawn and lever pressing was only reinforced by contingent presentation of the audiovisual stimuli. Under such a condition, responding persisted for 3 months, following which nonpresentation of the cues produced a progressive extinction of responding. As expected, rats trained to lever-press for saline injections paired with the audiovisual stimuli did not acquire the self-administration. These findings indicate that the cues required learned association with nicotine to acquire reinforcing properties and to function as conditioned reinforcers. When administered 1 month following nicotine withdrawal, rimonabant (1 mg/kg, i.p.) decreased conditioned behavior. These results showing the persistence of a nicotine-conditioned behavior are congruent with the role of nicotine-related environmental stimuli in nicotine craving in abstinent smokers. Rimonabant, which has been shown previously to reduce nicotine self-administration, may be effective not only as an aid for smoking cessation but also in the maintenance of abstinence.

Integrity signals

Registry

Crossref · 10.1038/sj.npp.1300541

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi, M. L., Barth, F., Héaulme, M., Shire, D. J., Calandra, B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,762
The reinstatement model of drug relapse: history, methodology and major findings
Shaham, Y., Shalev, U., Lu, L., de Wit, H., & Stewart, J. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1224-x · Cited by 1,615
Limbic Activation During Cue-Induced Cocaine Craving
Childress, A. R., Mozley, P. D., McElgin, W., Fitzgerald, J., Reivich, M., & O’Brien, C. P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.1.11 · Cited by 1,513
Factors That Predict Individual Vulnerability to Amphetamine Self-Administration
Piazza, P. V., Deminière, J.-M., Moal, M. L., & Simon, H. (1989) · Science · doi:10.1126/science.2781295 · Cited by 1,355
Subsecond dopamine release promotes cocaine seeking
Phillips, P. E. M., Stuber, G. D., Heien, M. L. A. V., Wightman, R. M., & Carelli, R. M. (2003) · Nature · doi:10.1038/nature01476 · Cited by 1,113
Incubation of cocaine craving after withdrawal
Grimm, J. W., Hope, B. T., Wise, R. A., & Shaham, Y. (2001) · Nature · doi:10.1038/35084134 · Cited by 1,031
The neuropsychological basis of addictive behaviour
Everitt, B. J., Dickinson, A., & Robbins, T. W. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(01)00088-1 · Cited by 808
Distribution of neuronal cannabinoid receptor in the adult rat brain: A comparative receptor binding radioautography and in situ hybridization histochemistry
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90409-u · Cited by 660
Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors
Arnone, M., Maruani, J., Chaperon, F., Thiébot, M.-H., Poncelet, M., Soubrié, P., & Fur, G. L. (1997) · Psychopharmacology · doi:10.1007/s002130050326 · Cited by 593
Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist
Pilla, M. A., Perachon, S., Sautel, F., Garrido, F., Mann, A., Wermuth, C. G., Schwartz, J.-C., Everitt, B. J., & Sokoloff, P. (1999) · Nature · doi:10.1038/22560 · Cited by 565

Flagged first, then by citations

Show all 51 references

Sorted by citations

Items 101–200 of 251

Mechanism-based medication development for the treatment of nicotine dependence
Xi, Z., Spiller, K. J., & Gardner, E. L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.46 · Cited by 42
Conditioned cues for smoking elicit preparatory responses in healthy smokers
Winkler, M. H., Weyers, P., Mucha, R. F., Stippekohl, B., Stark, R. M., & Pauli, P. (2010) · Psychopharmacology · doi:10.1007/s00213-010-2033-2 · Cited by 41
Therapeutic advances in the treatment of nicotine addiction: present and future
Casella, G., Caponnetto, P., & Polosa, R. (2010) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622310374896 · Cited by 42
The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction
Scherma, M., Fadda, P., Foll, B. L., Forget, B., Fratta, W., Goldberg, S. R., & Tanda, G. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927859 · Cited by 43
Surinabant, a selective cannabinoid receptor type 1 antagonist, inhibits Δ9‐tetrahydrocannabinol‐induced central nervous system and heart rate effects in humans
Klumpers, L. E., Roy, C., Ferron‐Brady, G., Turpault, S., Poitiers, F., Pinquier, J., van Hasselt, J. G. C., Zuurman, L., Erwich, F. A. S., & van Gerven, J. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12071 · Cited by 40
Pleiotropic impact of constitutive fosB inactivation on nicotine-induced behavioral alterations and stress-related traits in mice
Zhu, H., Lee, M.-S., Agatsuma, S., & Hiroi, N. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm027 · Cited by 39
New operant model of nicotine-seeking behaviour in mice
Martín‐García, E., Barbano, M. F., Galeote, L., & Maldonado, R. J. (2008) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145708009279 · Cited by 40
The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence
Muldoon, P. P., Lichtman, A. H., Parsons, L. H., & Damaj, M. I. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.015 · Cited by 39
A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats
de Bruin, N. M. W. J., McCreary, A. C., van Loevezijn, A., Vries, T. J. D., Venhorst, J., Drimmelen, M. V., & Kruse, C. G. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.048 · Cited by 37
Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice
Biała, G., & Kruk, M. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.04.004 · Cited by 37
Whole tobacco smoke extracts to model tobacco dependence in animals
Brennan, K. A., Laugesen, M., & Truman, P. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.014 · Cited by 39
Rimonabant: A cannabinoid receptor blocker for the treatment of metabolic and cardiovascular risk factors
Tonstad, S. (2006) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2005.10.011 · Cited by 36
Blocking the Cannabinoid Receptors: Drug Candidates and Therapeutic Promises
Muccioli, G. G. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790153 · Cited by 36
Nicotine Self-Administration Induces CB1-Dependent LTP in the Bed Nucleus of the Stria Terminalis
Reisiger, A.-R., Kaufling, J., Manzoni, O. J., Cador, M., Georges, F. E., & Caillé, S. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.3149-13.2014 · Cited by 37
The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on behavioural responses to nicotine
Tronci, V., Vronskaya, S., Montgomery, N., Mura, D., & Balfour, D. J. K. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1868-x · Cited by 35
Cannabinoid CB1 receptor antagonists as potential pharmacotherapies for drug abuse disorders
Beardsley, P. M., Thomas, B. F., & McMahon, L. R. (2009) · International Review of Psychiatry · doi:10.1080/09540260902782786 · Cited by 35
β‐Caryophyllene, a dietary terpenoid, inhibits nicotine taking and nicotine seeking in rodents
He, Y., Galaj, E., Bi, G., Wang, X., Gardner, E. L., & Xi, Z. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14969 · Cited by 33
Smoking Cessation Pharmacotherapy—Nicotine and Non‐Nicotine Preparations
Frishman, W. H. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.05963.x · Cited by 33
Nicotine reinforcement is reduced by cannabinoid CB1 receptor blockade in the ventral tegmental area
Simonnet, A., Cador, M., & Caillé, S. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00476.x · Cited by 34
Cannabinoid CB1 receptor antagonist rimonabant disrupts nicotine reward-associated memory in rats
Fang, Q., Li, F., Li, Y., Xue, Y.-X., He, Y., Liu, J., Lü, L., & Wang, J. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.06.019 · Cited by 33
Preclinical Evidence That Activation of Mesolimbic Alpha 6 Subunit Containing Nicotinic Acetylcholine Receptors Supports Nicotine Addiction Phenotype
Brunzell, D. H. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts089 · Cited by 36
Role of the prelimbic cortex in the acquisition, re-acquisition or persistence of responding for a drug-paired conditioned reinforcer
Ciano, P. D., Benham-Hermetz, J., Fogg, A. P., & Osborne, G. E. C. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.016 · Cited by 30
Naloxone and rimonabant reduce the reinforcing properties of exercise in rats.
Rasmussen, E. B., & Hillman, C. N. (2011) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0024142 · Cited by 31
The motivation to obtain nicotine-conditioned reinforcers depends on nicotine dose
Palmatier, M. I., Coddington, S. B., Liu, X., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.09.002 · Cited by 28
Effects of blockade of α4β2 and α7 nicotinic acetylcholine receptors on cue-induced reinstatement of nicotine-seeking behaviour in rats
Liu, X. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713000874 · Cited by 31
The relationship of personality traits to substance abuse in patients with bipolar disorder
Haro, G., Calabrese, J. R., Larsson, C., Shirley, E. R., Martín, E., Leal, C., & Delgado, P. L. (2007) · European Psychiatry · doi:10.1016/j.eurpsy.2007.03.009 · Cited by 28
Effects of the cannabinoid CB1 receptor antagonist AM 251 on the reinstatement of nicotine-conditioned place preference by drug priming in rats
Budzyńska, B., Kruk, M., & Biała, G. (2009) · Pharmacological Reports · doi:10.1016/s1734-1140(09)70036-2 · Cited by 27
Medicinal Cannabis and Central Nervous System Disorders
Ortiz, Y. T., McMahon, L. R., & Wilkerson, J. L. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.881810 · Cited by 29
Effects of rimonabant on the reinstatement of nicotine-conditioned place preference by drug priming in rats
Biała, G., Budzyńska, B., & Staniak, N. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.042 · Cited by 27
The Narghile (Hookah, Shisha, Goza) Epidemic and the Need for Clearing up Confusion and Solving Problems Related with Model Building of Social Situations
Chaouachi, K. T. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.255 · Cited by 27
Concurrent access to nicotine and sucrose in rats
Panlilio, L. V., Hogarth, L., & Shoaib, M. C. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3787-8 · Cited by 26
Neutral CB1 Receptor Antagonists as Pharmacotherapies for Substance Use Disorders: Rationale, Evidence, and Challenge
Soler‐Cedeño, O., & Xi, Z. (2022) · Cells · doi:10.3390/cells11203262 · Cited by 26
Role of endocannabinoids in regulating drug dependence
Parolaro, D. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s976 · Cited by 26
Inhibition of monoacylglycerol lipase (MAGL) enhances cue-induced reinstatement of nicotine-seeking behavior in mice
Trigo, J. M., & Foll, B. L. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4117-5 · Cited by 25
Rimonabant attenuates sensitization, cross-sensitization and cross-reinstatement of place preference induced by nicotine and ethanol
Biała, G., & Budzyńska, B. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70340-6 · Cited by 25
Denicotinized Versus Average Nicotine Tobacco Cigarette Smoking Differentially Releases Striatal Dopamine
Domino, E. F., Ni, L., Domino, J. S., Yang, W., Evans, C., Guthrie, S., Wang, H., Koeppe, R. A., & Zubieta, J. (2012) · Nicotine & Tobacco Research · doi:10.1093/ntr/nts029 · Cited by 24
Not all smokers appear to seek nicotine for the same reasons: implications for preclinical research in nicotine dependence
Garcia‐Rivas, V., & Deroche‐Gamonet, V. (2018) · Addiction Biology · doi:10.1111/adb.12607 · Cited by 32
Smoking cessation pharmacotherapy
Frishman, W. H. (2009) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944709335754 · Cited by 24
Effects of isoarecolone, a nicotinic receptor agonist in rodent models of nicotine dependence
Shoaib, M. C. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0498-9 · Cited by 23
Ethanol does not affect discriminative-stimulus effects of nicotine in rats
Foll, B. L., & Goldberg, S. R. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.06.051 · Cited by 23
The effect of previous exposure to nicotine on nicotine place preference
Pastor, V. E., Andrés, M. E., & Bernabeu, R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2928-1 · Cited by 22
Emerging pharmacotherapies for smoking cessation
Garwood, C. L., & Potts, L. A. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060427 · Cited by 22
Molecular Mechanisms Underlying the Motivational Effects of Nicotine
Brunzell, D. H., & Picciotto, M. R. (2008) · Nebraska Symposium on Motivation/The Nebraska symposium on motivation · doi:10.1007/978-0-387-78748-0_3 · Cited by 22
Expanding treatment of tobacco dependence
Harris, D. S., & Anthenelli, R. M. (2005) · Current Psychiatry Reports · doi:10.1007/s11920-005-0034-3 · Cited by 21
Effects of naltrexone on alcohol drinking patterns and extinction of alcohol seeking in baboons
Kaminski, B. J., Duke, A. N., & Weerts, E. M. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2688-y · Cited by 21
Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach
Foll, B. L., Pushparaj, A. P., Pryslawsky, Y., Forget, B., Vemuri, K. V., Makriyannis, A., & Trigo, J. M. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.10.009 · Cited by 20
Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications
Stoker, A. K., & Markou, A. (2015) · Current topics in behavioral neurosciences · doi:10.1007/978-3-319-13482-6_5 · Cited by 22
Effects of adolescent nicotine and SR 147778 (Surinabant) administration on food intake, somatic growth and metabolic parameters in rats
Lamota, L., Bermúdez‐Silva, F. J., Marco, E. M., Llorente, R., Gallego, A., de Fonseca, F. R., & Viveros, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.004 · Cited by 20
Sequential and simultaneous treatment approaches to cannabis use disorder and tobacco use
Lee, D. C., Walker, D. D., Hughes, J. R., Brunette, M. F., Scherer, E. A., Stanger, C., Etter, J., Auty, S. G., & Budney, A. J. (2018) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2018.12.005 · Cited by 19
Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial
Tonstad, S., & Aubin, H. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881111431623 · Cited by 19
A testosterone metabolite is rewarding to ovariectomized female rats.
Jorge, J. C., Velázquez, K. T., Ramos‐Ortolaza, D. L., Lorenzini, I., Marrero, J., & Maldonado-Vlaar, C. S. (2005) · Behavioral Neuroscience · doi:10.1037/0735-7044.119.5.1222 · Cited by 19
Low-dose nicotine self-administration is reduced in adult male rats naïve to high doses of nicotine: Implications for nicotine product standards.
Smith, T. T., Schassburger, R. L., Buffalari, D. M., Sved, A. F., & Donny, E. C. (2014) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0037396 · Cited by 18
Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors
Simonnet, A., Zamberletti, E., Cador, M., Rubino, T., & Caillé, S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.10.007 · Cited by 18
Extended nicotine self‐administration increases sensitivity to nicotine, motivation to seek nicotine and the reinforcing properties of nicotine‐paired cues.
Clemens, K. J., Lay, B. P. P., & Holmes, N. M. (2015) · Addiction Biology · doi:10.1111/adb.12336 · Cited by 16
Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB1 Receptor Antagonists after the Fall
Bosquez-Berger, T., Szanda, G., & Straiker, A. J. (2023) · Drugs and Drug Candidates · doi:10.3390/ddc2030035 · Cited by 17
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models
Smith, L. C., & George, O. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108225 · Cited by 18
Opioids and addiction: Emerging pharmaceutical strategies for reducing reward and opponent processes
Bryant, C. D., Zaki, P. A., Carroll, F. I., & Evans, C. J. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.006 · Cited by 16
The CB1 cannabinoid receptor antagonist rimonabant chronically prevents the nicotine-induced relapse to alcohol
López‐Moreno, J. A., González‐Cuevas, G., & Navarro, M. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.09.010 · Cited by 16
Cognitive control deficits during mecamylamine-precipitated withdrawal in mice: Possible links to frontostriatal BDNF imbalance
Parikh, V., Cole, R. D., Patel, P., Poole, R. L., & Gould, T. J. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.01.003 · Cited by 15
A second‐order schedule of food reinforcement in rats to examine the role of CB1 receptors in the reinforcement‐enhancing effects of nicotine
Wing, V. C., & Shoaib, M. C. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00203.x · Cited by 15
Evaluation of Rhodiola rosea L. extract on affective and physical signs of nicotine withdrawal in mice
Mattioli, L., & Perfumi, M. C. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109348166 · Cited by 15
A behavioral and pharmacological characterization of palatable diet alternation in mice
Moore, C. F., Schlain, G. S., Mancino, S., Sabino, V., & Cottone, P. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.10.013 · Cited by 16
Molecular, Neuronal, and Behavioral Effects of Ethanol and Nicotine Interactions
Klenowski, P. M., & Tapper, A. R. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2017_89 · Cited by 15
Rimonabant for treating tobacco dependence.
Steinberg, M. B., & Foulds, J. (2007) · PubMed Central · Cited by 15
New Insights in the Involvement of the Endocannabinoid System and Natural Cannabinoids in Nicotine Dependence
Saravia, R., Ten-Blanco, M., Pereda-Pérez, I., & Berrendero, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413316 · Cited by 14
Novel therapeutic and drug development strategies for tobacco use disorder: endocannabinoid modulation
Butler, K., & Foll, B. L. (2020) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2020.1767581 · Cited by 14
The psychobiology of nicotine dependence
Balfour, D. J. K. (2008) · European Respiratory Review · doi:10.1183/09059180.00011001 · Cited by 14
Fatty Acid-Binding Protein 5 Gene Deletion Enhances Nicotine-Conditioned Place Preference: Illuminating the Putative Gateway Mechanisms
Roeder, N. M., Richardson, B., Mihalkovic, A., Penman, S. L., White, O., Hamilton, J., Gupta, A., Blum, K., Gold, M. S., & Thanos, P. K. (2023) · Future Pharmacology · doi:10.3390/futurepharmacol3010007 · Cited by 13
Bifeprunox: a partial agonist at dopamine D2 and serotonin1A receptors, influences nicotine‐seeking behaviour in response to drug‐associated stimuli in rats
Clemente, A. D., Franchi, C., Orrù, A., Arnt, J., & Cervo, L. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00319.x · Cited by 13
Investigation of endocannabinoid modulation of conditioned responding evoked by a nicotine CS and the Pavlovian stimulus effects of CP 55,940 in adult male rats
Murray, J. E., Wells, N. R., Lyford, G. D., & Bevins, R. A. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1572-x · Cited by 12
The effects of nicotine on conditioning, extinction, and reinstatement in humans
Palmisano, A. N., Hudd, E. C., McQuade, C., de Wit, H., & Astur, R. S. (2017) · Addictive Behaviors · doi:10.1016/j.addbeh.2017.09.008 · Cited by 12
Preclinical and clinical research on the discriminative stimulus effects of nicotine
Shoaib, M. C., & Perkins, K. A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108063 · Cited by 12
An extended history of drug self-administration results in multiple sources of control over drug seeking behavior
Clemens, K. J., & Holmes, N. M. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.11.011 · Cited by 11
Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats
Kelsey, J. E., & Calabro, S. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0913-x · Cited by 12
Emergence of Dormant Conditioned Incentive Approach by Conditioned Withdrawal in Nicotine Addiction
Scott, D., & Hiroi, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.05.017 · Cited by 11
Context-dependent effects of rimonabant on ethanol-induced conditioned place preference in female mice
Silva, A. A. F., Barbosa-Souza, E., Confessor-Carvalho, C., Silva, R. R. R., Brito, A. C., Cata-Preta, E. G., Oliveira, T. S., Berro, L. F., Oliveira-Lima, A. J., & Marinho, E. A. V. (2017) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2017.07.019 · Cited by 11
Neurobiology of Stress-Induced Nicotine Relapse
Wang, X., Chen, Y., Dong, J., Ge, J., Liu, X., & Liu, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031482 · Cited by 10
Targeting the α4β2- and α7-Subtypes of Nicotinic Acetylcholine Receptors for Smoking Cessation Medication Development.
Nair, L. R., & Liu, X. (2019) · PubMed · Cited by 10
The CB1R rs2023239 receptor gene variant significantly affects the reinforcing effects of nicotine, but not cue reactivity, in human smokers
Chukwueke, C. C., Kowalczyk, W. J., Gendy, M. N. S., Taylor, R., Tyndale, R. F., Foll, B. L., & Heishman, S. J. (2020) · Brain and Behavior · doi:10.1002/brb3.1982 · Cited by 10
Second‐order schedules of nicotine reinforcement in rats: effect of AM251
Wing, V. C., & Shoaib, M. C. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2009.00204.x · Cited by 10
Hypothalamic Regulatory Pathways and Potential Obesity Treatment Targets
Jobst, E. E., Enriori, P. J., Sinnayah, P., & Cowley, M. A. (2006) · Endocrine · doi:10.1385/endo:29:1:33 · Cited by 10
Topiramate does not alter nicotine or cocaine discrimination in rats
Foll, B. L., Justinová, Z., Wertheim, C. E., Barnes, C., & Goldberg, S. R. (2008) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3282f3cf84 · Cited by 10
Recent advances in the treatment of tobacco dependence
Anthenelli, R. M. (2005) · Clinical Neuroscience Research · doi:10.1016/j.cnr.2005.08.014 · Cited by 10
Review: The endocannabinoid system: a new therapeutic target for cardiovascular risk factor management
Finer, N., & Pagotto, U. (2005) · The British Journal of Diabetes · doi:10.1177/14746514050050030201 · Cited by 10
Detrimental Effects of a Retrieval-Extinction Procedure on Nicotine Seeking, but Not Cocaine Seeking
Struik, R. F., Vries, T. J. D., & Peters, J. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00243 · Cited by 9
Therapeutic potential of PIMSR, a novel CB1 receptor neutral antagonist, for cocaine use disorder: evidence from preclinical research
Galaj, E., Hempel, B. J., Moore, A. R., Klein, B., Bi, G., Gardner, E. L., Seltzman, H. H., & Xi, Z. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02059-w · Cited by 9
Endocannabinoids regulate cocaine-associated memory through brain AEA–CB1R signalling activation
Li, H., Chen, R., Zhou, Y., Wang, H., Sun, L., Yang, Z., Bai, L., & Zhang, J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101597 · Cited by 8
Effects of chronic nicotine exposure on Δ9-tetrahydrocannabinol-induced locomotor activity and neural activation in male and female adolescent and adult rats
Miladinovic, T., Manwell, L. A., Raaphorst, E., Malecki, S. L., Rana, S. A., & Mallet, P. E. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172931 · Cited by 7
Interactions of Cannabinoids With Biochemical Substrates
Thomas, B. F. (2017) · Substance Abuse Research and Treatment · doi:10.1177/1178221817711418 · Cited by 7
6 Recent Progress in Cannabinoid Research
Adam, J., Cowley, P. M., Kiyoi, T., Morrison, A. J., & Mort, C. (2006) · Progress in medicinal chemistry · doi:10.1016/s0079-6468(05)44406-9 · Cited by 7
Attentional capacities prior to drug exposure predict motivation to self-administer nicotine
Vandaele, Y., Noe, E., Cador, M., Dellu-Hagedorn, F., & Caillé, S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4901-0 · Cited by 6
Associative processes in addiction relapse models: A review of their Pavlovian and instrumental mechanisms, history, and terminology
Lay, B. P. P., & Khoo, S. Y. (2021) · Neuroanatomy and Behaviour · doi:10.35430/nab.2021.e18 · Cited by 4
Neuroanatomical basis for therapeutic applications of cannabinoid receptor 1 antagonists
Thomas, B. F. (2009) · Drug Development Research · doi:10.1002/ddr.20333 · Cited by 5
Cannabinoid-Nicotine Interactions
Auber, A., Justinová, Z., Scherma, M., Goldberg, S. R., & Panlilio, L. V. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_13 · Cited by 4
Individual variations in motives for nicotine self-administration in male rats: evidence in support for a precision psychopharmacology
Garcia‐Rivas, V., Fiancette, J.-F., Tostain, J., de Maio, G., Ceau, M., Wiart, J., Gaulier, J., & Deroche‐Gamonet, V. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02774-6 · Cited by 4
Endocannabinoid Signaling in Reward and Addiction: From Homeostasis to Pathology
Laredo, S. A., Marrs, W., & Parsons, L. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_10 · Cited by 5
The Role of the Endocannabinoid System in Addiction
Trigo, J. M., & Foll, B. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809666-6.00006-x · Cited by 4
Differential roles of diacylglycerol lipase (DAGL) enzymes in nicotine withdrawal
Buzzi, B., Köşeli, E., Alkhlaif, Y., Parker, A., Mustafa, M. A., Lichtman, A. H., Buczynski, M. W., & Damaj, M. I. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148483 · Cited by 3
The Absence of Blocking Innicotine High-Responders as a Possible Factor in the Development of Nicotine Dependence?
Jaffe, A., Pham, J. A. Z., Tarash, I., Getty, S. S., Fanselow, M. S., & Jentsch, J. D. (2014) · The Open Addiction Journal · doi:10.2174/1874941001407010008 · Cited by 4
Pharmakologische Strategien zur Unterstützung einer Raucherentwöhnung
Vasić, N., Wolf, R. C., Wolf, N. D., Connemann, B. J., & Sosic-Vasic, Z. (2011) · Der Nervenarzt · doi:10.1007/s00115-010-3203-5 · Cited by 3

Authors: Cohen, C., Perrault, G., Griebel, G., & Soubrié, P.
Affiliations: Sanofi (France) (FR)
Corresponding author: Cohen, Caroline
ORCID: Griebel, Guy
Venue: Neuropsychopharmacology
Publisher: Springer Science and Business Media LLC
Published: 2004-08-04
Volume: 30
Issue: 1
Pages: 145-155
ISSN: 0893-133X (ISSN-L)
1740-634X
DOI: 10.1038/sj.npp.1300541
OpenAlex: W2070212982
Cited by: 251
References: 51
Citations by year: 2025: 1 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 4 · 2017: 11 · 2016: 11 · 2015: 10 · 2014: 10 · 2013: 8 · 2012: 15
FWCI: 16.24
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Neuropsychopharmacology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
Keywords: nicotine, nicotine withdrawal, conditioned cues, rimonabant, endocannabinoid system, extinction resistance, conditioned reinforcement, nicotine self-administration, smoking cessation, nicotine dependence, relapse
MeSH terms: Rimonabant, Acoustic Stimulation, Animals, Cues, Dopamine, Environment, Extinction, Psychological, Light, Male, Motivation, Motor Activity, Synaptic Transmission, Nicotine, Piperidines, Pyrazoles, Self Administration, Substance Withdrawal Syndrome, Tobacco Use Disorder, Rats, Sprague-Dawley, Nicotinic Agonists, Receptor, Cannabinoid, CB1, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Nicotine-Associated Cues Maintain Nicotine-Seeking Behavior in Rats Several Weeks after Nicotine Withdrawal: Reversal by the Cannabinoid (CB1) Receptor Antagonist, Rimonabant (SR141716)

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks